Perioperative renin-angiotensin blockade: To continue or discontinue, that is the question!

Anesthesia and Analgesia

Volumn 118, Issue 5, 2014, Pages 909-911

  Sear, John W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; AMIODARONE; ANESTHETIC AGENT; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HERBACEOUS AGENT; MINERAL; NON PRESCRIPTION DRUG; NORADRENALIN; PRESCRIPTION DRUG; THIOPENTAL; VITAMIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

AMBULATORY SURGERY; BLOOD PRESSURE; BLOOD VESSEL TONE; CARDIOVASCULAR RESPONSE; DIABETIC NEPHROPATHY; DIARRHEA; DISEASE CONTROL; DISEASE COURSE; GENERAL ANESTHESIA; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; INCIDENCE; INTUBATION; KIDNEY DISTAL TUBULE; LARYNGOSCOPY; MONOTHERAPY; MORBIDITY; MORTALITY; PARASYMPATHETIC TONE; PERIOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SURVIVAL; SYMPATHETIC NERVE; SYMPTOM; SYSTEMIC VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANESTHESIA; DRUG EFFECT; EDITORIAL; METHODOLOGY;

ANESTHESIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; HUMANS; PERIOPERATIVE CARE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84902214801     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000204     Document Type: Review

References (19)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002;287:337-44.
2. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867-78.
3. Wolf A, McGoldrick KE. Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia. Cardiol Rev 2011;19:12-6.
4. Colson P, Saussine M, Séguin JR, Cuchet D, Chaptal PA, Roquefeuil B. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1992;74:805-8.
5. Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, Viars P. Influence of chronic angiotensin- converting enzyme inhibition on anesthetic induction. Anesthesiology 1994;81:299-307.
6. Pigott DW, Nagle C, Allman K, Westaby S, Evans RD. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth 1999;83:715-20.
7. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001;92:26-30.
8. Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, Danielson DR, Liedl L, Warner DO. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005;100:636-44.
9. Weisenberg M, Sessler DI, Tavdi M, Gleb M, Ezri T, Dalton JE, Protianov M, Zimlichmann R. Dose-dependent hemodynamic effects of propofol induction following brotizolam premedication in hypertensive patients taking angiotensin-converting enzyme inhibitors. J Clin Anesth 2010;22:190-5.
10. Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, La Bella M, Montori VM. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med 2008;3:319-25.
11. Sear JW, Jewkes C, Tellez JC, Foëx P. Does the choice of antihypertensive therapy influence haemodynamic responses to induction, laryngoscopy and intubation? Br J Anesth 1994;73:303-8.
12. Schulte E, Ziegler D, Philippi-Höhne C, Kaczmarczyk G, Boemke W. Angiotensin-converting enzyme inhibition and blood pressure response during total intravenous anaesthesia for minor surgery. Acta Anesthesiol Scand 2011;55:435-43.
13. Licker M, Schweizer A, Höhn L, Farinelli C, Morel DR. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors. Can J Anesth 2000;47:433-40.
14. Prys-Roberts C. Withdrawal of antihypertensive drugs before anesthesia. Anesth Analg 2002;94:767-8.
15. Behnia R, Molteni A, Igić R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des 2003;9:763-76.
16. Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE. Renin- Angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anesth 2010;57:736-44.
17. Toppin J, Naughton F, Wijeysundera D, Tait G, Beattie S. ACE inhibitors reduce 30 day mortality after non-cardiac surgery. Abstracts SCA 2011;SCA 64.
18. Turan A, You J, Shiba A, Kurz A, Saager L, Sessler DI. Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth Analg 2012;114:552-60.
19. Twersky R, Goel V, Narayan P, Weedon J. Risk of hypertension after preoperative discontinuation of angiotensin converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same day admission patients. Anesth Analg 2014.